Molecular cloning and characterization of novel human JNK2 (MAPK9) transcript variants that show different stimulation activities on AP-1
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
The c-Jun NH2-terminal kinase (JNK) signaling pathway participates in many physiological functions. In the current study we reported the cloning and characterization of five novel JNK2transcript variants, which were designated as JNK2α3, JNK2α4,JNK2β3, JNK2γ1 and JNK2γ2, respectively. Among them,JNK2α4 and JNK2γ2 are potential non-coding RNA because they contain pre-mature stop codons. Both JNK2α3 and JNK2β3contain an intact kinase domain, and both encode a protein product of 46 kDa, the same as those of JNK2α1 and JNK2β1. JNK2γ1 contains a disrupted kinase domain and it showed a disable function. When over-expressed in mammalian cells,JNK2α3 showed higher activity on AP-1 than that of JNK2β3and JNK2γ1. Furthermore, JNK2α3 and JNK2β3 showed different levels of substrate phosphorylation, although they both could promote the proliferation of 293T cells. Our results further demonstrate that JNK2 isoforms preferentially target different substrates and may regulate the expression of various target genes.
Abstract
The c-Jun NH2-terminal kinase (JNK) signaling pathway participates in many physiological functions. In the current study we reported the cloning and characterization of five novel JNK2transcript variants, which were designated as JNK2α3, JNK2α4,JNK2β3, JNK2γ1 and JNK2γ2, respectively. Among them,JNK2α4 and JNK2γ2 are potential non-coding RNA because they contain pre-mature stop codons. Both JNK2α3 and JNK2β3contain an intact kinase domain, and both encode a protein product of 46 kDa, the same as those of JNK2α1 and JNK2β1. JNK2γ1 contains a disrupted kinase domain and it showed a disable function. When over-expressed in mammalian cells,JNK2α3 showed higher activity on AP-1 than that of JNK2β3and JNK2γ1. Furthermore, JNK2α3 and JNK2β3 showed different levels of substrate phosphorylation, although they both could promote the proliferation of 293T cells. Our results further demonstrate that JNK2 isoforms preferentially target different substrates and may regulate the expression of various target genes.
참고문헌 (20)
- Weston, C. R., "The JNK signal transduction pathway", Curr. Opin. Cell Biol., 19, pp.142~149 (2007)
- Dhanasekaran, D. N., "JNK signaling in apoptosis", Oncogene, 27, pp.6245~6251 (2008)
- Davis, R. J., "Signal transduction by the JNK group of MAP kinases", Cell, 103, pp.239~252 (2000)
- Bode, A. M., "The functional contrariety of JNK", Mol. Carcinog., 46, pp.591~598 (2007)
- Gupta, S., "Selective interaction of JNK protein kinase isoforms with transcription factors", EMBO J., 15, pp.2760~2770 (1996)
- Kallunki, T., "JNK2 contains a specificity-determining region responsible for efficient c-Jun binding and phosphorylation", Genes Dev., 8, pp.2996~3007 (1994)
- Tsuiki, H., "Constitutively active forms of c-Jun NH2-terminal kinase are expressed in primary glial tumors", Cancer Res., 63, pp.250~255 (2003)
- Dreskin, S. C., "Isoforms of Jun kinase are differentially expressed and activated in human monocyte", macrophage (THP-1) cells, 2001, pp.166, 5646~5653
- Matlin, A. J., "Understanding alternative splicing: towards a cellular code", Nat. Rev. Mol. Cell Biol., 6, pp.386~398 (2005)
- Wang, E. T., "Alternative isoform regulation in human tissue transcriptomes", Nature, 456, pp.470~476 (2008)
- Wang, P., "Discovery of novel human transcript variants by analysis of intronic single-block EST with polyadenylation site", BMC Genomics., 10, pp.518~ (2009)
- McGlincy, N. J., "Alternative splicing resulting in nonsense-mediated mRNA decay: what is the meaning of nonsense?", Trends. Biochem. Sci., 33, pp.385~393 (2008)
- Kyriakis, J. M., "Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation", Physiol. Rev., 81, pp.807~869 (2001)
- Pimienta, G., "Autophosphorylation properties of inactive and active JNK2", Cell Cycle, 6, pp.1762~1771 (2007)
- Cui, J., "Identification of a specific domain responsible for JNK2alpha2 autophosphorylation", J. Biol. Chem., 280, pp.9913~9920 (2005)
- Jaeschke, A., "JNK2 is a positive regulator of the cJun transcription factor", Mol. Cell, 23, pp.899~911 (2006)
- Nitta, R. T., "Constitutive activity of JNK2 alpha2 is dependent on a unique mechanism of MAPK activation", J. Biol. Chem., 283, pp.34935~34945 (2008)
- Shaulian, E., "AP-1 as a regulator of cell life and death", Nat. Cell Biol., 4, pp.E131~E136 (2002)
- Eferl, R., "AP-1: a double-edged sword in tumorigenesis", Nat. Rev. Cancer, 3, pp.859~868 (2003)
- Wang, P., "Cloning of a novel human caspase-9 splice variant containing only the CARD domain", Life Sci., 79, pp.934~940 (2006)